Angiogenesis in ophthalmology. Part 2: Current considerations on the pathogenesis of diabetic and hypoxia-induced retinopathy;Angiogenese in der augenheilkunde, teil 2: Aktuelle überlegungen zur pathogenese der diabetischen retinopathie und der hypoxie-induzierten retinopathie

Ophthalmologe

Volumn 100, Issue 5, 2003, Pages 361-362

  Joussen, Antonia M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; SOMATOMEDIN; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ANGIOGENESIS; DIABETES MELLITUS; DIABETIC RETINOPATHY; EDITORIAL; HUMAN; PATHOPHYSIOLOGY; RETINA NEOVASCULARIZATION; SIGNAL TRANSDUCTION;

EID: 0037600425     PISSN: 0941293X     EISSN: 14330423     Source Type: Journal    
DOI: 10.1007/s00347-003-0830-2     Document Type: Editorial

References (12)

1. Fanatsu H, K Yamashita, H Noma, T Yamashita and S Hori (2002) Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol 2002 133: 70-77
2. Giannini S, B Cresci, L Pala, A Ciucci, A Franchini, C Manuelli, Y Fujita-Yamaguchi, P Cappugi, R Zonefrati and C M Rotella (2001) IGFBPs modulate IGF-I- and high glucose-controlled growth of human retinal endothelial cells. J Endocrinol 171: 273-284
3. Joussen A M, T Murata, A Tsujikawa, B Kirchhof, S E Bursell and A P Adamis (2001) Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina. Am J Pathol 158: 147-152
4. Joussen A M, V Poulaki, N Mitsiades, B Kirchhof, K Koizumi, S Doehmen and A P Adamis (2002) Potential use of non-steroidal anti-inflammatory drugs for prvention of diabetic vascular changes: Aspirin prevents diabetic leakage and leukocyte adhesion through inhibition of TNF-a. FASEB J 16: 438-440
5. Joussen A M, V Poulaki, A Tsujukawa, W Qin, S Wigand, E Jaffe, G D Yancopoulos and A P Adamis (2002) Angiopoietin-1 prevents early diabetic vascular changes. Am J Pathol 160: 501-509
6. Lip P L, F Belgore, A D Blann, M W Hope-Ross, J M Gibson and G Y Lip (2000) Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci 41: 2115-2119
7. Maini R S C E, Breedveld F, Furst D, Kalden J, Weisman M, and E P Smolen J, Harriman G, Feldmann M, Lipsky P (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 354: 1932-1939
8. Miyamoto K, S Khosrof, S-E Bursell, Y Moromizato, L P Aiello, Y Ogura and A P Adamis (2000) Vascular endothelial growth factor-induced retinal vascular permeability is nediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol 156: 1733-1739
9. Nonaka A, J Kiryu, A Tsujikawa, K Yamashiro, K Miyamoto, H Nishiwaki, Y Honda and Y Ogura (2000) PKC-β inhibitor (LY333531) attenuates leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthalmol Vis Sci 41: 2702-2706
10. Oku H, T Kida, T Sugiyama, J Hamada, B Sato and T Iketa (2001) Possible involvement of endothelin-1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy. Retina 21: 647-651
11. Soriano F G, L Virag and C Szabo (2001) Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly (ADPribose) polymerase activation. J Mol Med 79: 437-448
12. Weinblatt M E, J M Kremer, A D Bankhurst, K J Bulpitt, R M Fleischmann, R I Fox, C G Jackson, M Lange and D J Burge (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340: 253-259